Position in WAT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,673,039
New position
Shares Held
5,618
first reported quarter
Ownership
0.006%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 70.64634490544735.ToString("F0")%
Shared 20.80158058142817.ToString("F0")%
None 8.55207451312447.ToString("F0")%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026PEAPACK GLADSTONE FINANCIAL CORP holds $62,706,980 across 9 Diagnostics & Research names. WAT ranks #5 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
49,748 | $24,452,632 | |
| 2 | LH |
Labcorp Holdings Inc.
|
88,873 | $23,712,203 | |
| 3 | DHR |
Danaher Corp /De/
|
50,862 | $9,643,435 | |
| 4 | DGX |
Quest Diagnostics Inc
|
10,945 | $2,145,000 | |
| 5 | WAT |
Waters Corp /De/
This page
|
5,618 | $1,673,039 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
823 | $462,435 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
285 | $359,442 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
1,369 | $233,469 |
All Filings in WAT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,673,039 | 5,618 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||